Establishment of a bipedal rat model of lumbar facet joint osteoarthritis using intraarticular injection of urinary plasminogen activator

J Orthop Surg Res. 2022 Oct 12;17(1):447. doi: 10.1186/s13018-022-03339-3.

Abstract

Background: Previous studies have demonstrated that by injecting uPA into the lumbar facet joints (LFJ) of normal rats, a rat LFJOA animal model can be successfully established. However, there is no evidence that intraarticular injection of uPA can induce or much serious osteoarthritis in bipedal rats, which biomechanics is much more similar to human than normal rats. To investigate whether intraarticular injection of urinary plasminogen activator (uPA) can induce LFJOA and low back pain symptoms in bipedal rats.

Methods: An experimental study on the construction of a modified animal model of lumbar facet joints osteoarthritis (LFJOA) which biomechanics is similar to human. Sprague-Dawley rats were treated with intraarticular injection of uPA in the L5-L6 facet joints (uPA group, n = 15) or saline (saline group, n = 15). The forelimbs of both two group rats were amputated. Mechanical and thermal hyperalgesia in the ipsilateral hind paws were evaluated using von Frey hairs and a thermoalgesia instrument, respectively. Toluidine blue staining, hematoxylin-eosin staining, and immunohistochemical examination of the LFJ was performed.

Results: The saline group rats have not demonstrated significant osteoarthritis in rats LFJ after surgery. The uPA group has not been induced significantly higher mechanical and thermal hyperalgesia in comparison with the saline group. But intraarticular injection of uPA in biped rats induced significantly stronger articular cartilage damage, synovitis, and proliferation of synovial cells in the LFJ. Inflammatory factors such as iNOS, IL-1β, and TNF-a were more significantly expressed in bipedal rat injected with uPA (p < 0.05).

Conclusions: Intraarticular injection of uPA can induce LFJOA in bipedal rats, while upright posture does not induce osteoarthritis in rats LFJ in the short term.

Keywords: Animal model; Bipedal rat; Low back pain; Lumbar facet joint osteoarthritis; Urinary plasminogen activator.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Eosine Yellowish-(YS) / therapeutic use
  • Hematoxylin / therapeutic use
  • Humans
  • Hyperalgesia
  • Injections, Intra-Articular
  • Osteoarthritis* / drug therapy
  • Rats
  • Rats, Sprague-Dawley
  • Tolonium Chloride / therapeutic use
  • Urokinase-Type Plasminogen Activator / therapeutic use
  • Zygapophyseal Joint*

Substances

  • Tolonium Chloride
  • Urokinase-Type Plasminogen Activator
  • Eosine Yellowish-(YS)
  • Hematoxylin